Glaxo Smith Kline (BIOC)

Last update: 10 September 01:29 PM market time.

288.85

242.02

514.06%

Open 305.00

Previous Close 47.08

High 309.00

Low 285.00

Stock Statistics

Volume 195,718

Turnover 57,494,088.00

All data are 15 minutes late during market session

Announcements

4 November 2025 03:39 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - AGM Minutes (after Certification)

12 August 2025 10:21 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Consolidated Results

12 August 2025 09:46 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Standalone Results

12 August 2025 09:44 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

27 July 2025 03:09 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

16 June 2025 09:27 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Auditor's Report on the Corporate Governance Report in English

29 May 2025 09:35 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - AGM Decisions

28 May 2025 03:15 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Corporate Governance Report

14 May 2025 09:29 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

5 May 2025 03:28 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form concerning the BoD & the Shareholders' Structure

4 May 2025 03:06 PM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the AGM

9 March 2025 10:29 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports Year Ended 31/12/2024 Consolidated Results

9 March 2025 10:20 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

15 January 2025 04:17 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

14 November 2024 11:07 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

14 November 2024 11:03 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 9 Months Consolidated Results

15 October 2024 08:52 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

15 August 2024 09:18 AM Egyptian Stock Exchange Release from Glaxo Smith Kline (BIOC.CA) Concerning the BoD & the Executive Managers

14 August 2024 09:26 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) Reports 6 Months Consolidated Results

14 August 2024 09:22 AM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Board of Directors' Decisions

15 July 2024 03:19 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure

9 July 2024 02:39 PM Egyptian Stock Exchange Glaxo Smith Kline (BIOC.CA) - Disclosure Form Concerning the BoD & the Shareholders' Structure